Al-Dhahry, S. H., Al-Awaidy, S. T., Al-Busaidy, S. M., Koul, R. L., Al-Khusaiby, S. M., & Suleman, A. J. (2001). Poliomyelitis in Oman. II. Toward eradication. Acta tropica, 80(2), 131-138

Centers for Disease Control and Prevention. (2015b). Epidemiology and Prevention. of Vaccine-Preventable Diseases: Poliomyelitis.

Centers for Disease Control and Prevention. (2018e). Polio Vaccine: What everyone should know. 

Fitzpatrick, M. (2006). The Cutter incident: How America’s first polio vaccine led to a growing vaccine crisis.  Journal of the Royal Society of Medicine. 99(3): 156

Global Polio Eradication Initiative (n.d.) Surveillance

Gorson, K. C., & Ropper, A. H. (2001). Nonpoliovirus poliomyelitis simulating Guillain-Barré syndrome. Archives of neurology, 58(9), 1460-1464.

Ochmann, S. & Roser, M. (2017). Polio: Our World in Data.

Nathanson, N., & Kew, O. M. (2010). From emergence to eradication: the epidemiology of poliomyelitis deconstructed. American journal of epidemiology, 172(11), 1213-1229

Platt, L. R., Estívariz, C. F., & Sutter, R. W. (2014). Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden. The Journal of infectious diseases, 210(suppl_1), S380-S389

Sutter, R. W., Patriarca, P. A., Cochi, S. L., Pallansch, M. A., Kew, O. M., Hall, D. B., … & EI-Bualy, M. S. (1991). Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. The Lancet, 338(8769), 715-720

World Health Organization (n.d.) Acute Flaccid Paralysis (AFP) surveillance: the surveillance strategy for poliomyelitis eradication

World Health Organization.(2017b).  What is vaccine-derived polio?